L&C BIO

The current price of 290650 is 20200 KRW — it has decreased by 0.49% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange L&C BIO stocks are traded under the ticker 290650.

290650 stock is 1.50% volatile and has beta coefficient of 0.75. Check out the list of the most volatile stocks — is L&C BIO there?

L&C BIO revenue for the last quarter amounts to ‪7.90 B‬ KRW despite the estimated figure of ‪10.80 B‬ KRW. In the next quarter revenue is expected to reach ‪12.30 B‬ KRW.

Yes, you can track L&C BIO financials in yearly and quarterly reports right on TradingView.

290650 stock has fallen by 4.49% compared to the previous week, the month change is a 12.17% fall, over the last year L&C BIO has showed a 36.28% decrease.

290650 net income for the last quarter is ‪−3.41 B‬ KRW, while the quarter before that showed ‪49.80 B‬ KRW of net income which accounts for −106.84% change. Track more L&C BIO financial stats to get the full picture.

Yes, 290650 dividends are paid annually. The last dividend per share was 100.00 KRW. As of today, Dividend Yield (TTM)% is 0.50%. Tracking L&C BIO dividends might help you take more informed decisions.

L&C BIO dividend yield was 0.34% in 2023, and payout ratio reached 4.69%. The year before the numbers were 0.22% and 24.96% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.

Like other stocks, 290650 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade L&C BIO stock right from TradingView charts — choose your broker and connect to your account.

290650 reached its all-time high on Oct 6, 2020 with the price of 51850 KRW, and its all-time low was 5000 KRW and was reached on Aug 6, 2019.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 123.00 employees. See our rating of the largest employees — is L&C BIO on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So L&C BIO technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating L&C BIO stock shows the sell signal. See more of L&C BIO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. L&C BIO EBITDA is ‪14.06 B‬ KRW, and current EBITDA margin is 20.41%. See more stats in L&C BIO financial statements.